Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Discover which cash back cards have no fees. Find your ideal card and enjoy rewards without extra costs.
28,185 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Energy refuses quit: stocks keep leading gains into June 2026, with the XLE ETF rising and major oil names driving th...
Oil markets surged as geopolitical tensions flared, with brent crude briefly topping the $119 mark. This article outl...
NexaTech Holdings, a $40 billion market-cap company, raised its revenue guidance on stronger-than-expected demand, si...
The SNPD ETF is widening its search for dividend growth by applying a 10-year growth screen to identify the next gene...
In a volatile 2026 market, retirees are choosing stability over constant client chasing. Experts say build income fir...
The memory market has been on a wild ride. After sharp gains earlier this year, Micron and SanDisk pulled back, promp...
HF Sinclair delivered a solid earnings beat, but shares fell sharply after leadership news. This article breaks down ...
PayPal is broadening its blockchain-enabled trade-financing push for the trucking sector, enabling token-to-stablecoi...
When a top executive sells stock, the market takes notice. This deeper look at Bristow Group's just sold helps you se...
Discover how Hudson Pacific Properties is shaping its 2026 path after Q1 results. This guide breaks down earnings sig...
Stocks drift lower in mid-June 2026 as investors reassess AI and chip names. This guide lays out what look when buyin...